Ctd Holdings, Inc. (QB) Stock Price - CTDH

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 0.24 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Ctd Holdings, Inc. (QB) CTDH OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.002 0.84% 0.24 0.249 0.226 0.249 0.238 16:29:53
Bid Price Ask Price Spread Spread % News
0.23 0.25 0.02 8.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
58 203,570 $ 0.236309 $ 48,105 158,445 0.155 - 1.18
Last Trade Time Type Quantity Stock Price Currency
15:54:07 5,000 $ 0.24 USD

Ctd Holdings, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.09M 121.22M $ -4.26M - - 26.30M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
124.70k $ - 0.00% - -

more financials information »

Ctd Holdings, Inc. (QB) News

Loading Messages....

Latest CTDH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTDH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.190.2540.170.2301837482,4270.0526.32%
1 Month0.180550.2540.170.2148401186,8320.0594532.93%
3 Months0.2150.2540.1550.1988323162,5970.02511.63%
6 Months0.610.8390.1550.2253384104,010-0.37-60.66%
1 Year0.851.180.1550.269275466,186-0.61-71.76%
3 Years0.50291.180.1550.330125633,557-0.2629-52.28%
5 Years0.62011.180.1550.365593625,485-0.3801-61.3%

Ctd Holdings, Inc. (QB) Description

CTD Holdings, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of diseases with unmet need. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product in the United States and the EU, is used to treat Niemann-Pick Type C, a rare and fatal genetic disease. Additional indications for the active ingredient in Trappsol(R) Cyclo(TM) are in development. For additional information, visit the company's website: www.ctd-holdings.com

Your Recent History
Ctd Holdin..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.